Illustrative image – not actual.Bangalore-based biotechnology firm Biocon Ltd has given CCM Pharmaceuticals, a subsidiary of Chemical Company of Malaysia, exclusive licence and distribution rights for its insulin products in Malaysia and Brunei.
The collaboration was in line with CCM's vision to pursue strategic partnerships to strengthen its pharmaceutical division's equity and portfolio in niche therapeutic areas such as oncology, biosimilars and vaccines
Source: Economic Times
